INTRODUCTION
Obesity and overweight, especially among children, are considered as major health concerns. A growing body of evidence suggests that the complications of obesity in adulthood begin in early childhood. In recent years, the worldwide prevalence of overweight has increased significantly among children. In addition to the Western countries, [1] childhood obesity is increasing in developing countries; it has become an emerging public health, which in turn would result in socioeconomic and public health burden in these countries in the near future.
Endothelium has an important role in regulating vascular tone, platelet activity, and thrombosis; it is mainly involved in the development of atherosclerosis. Endothelial dysfunction has been determined in patients with established coronary artery disease or coronary risk factors, both in the coronary and peripheral vessels. [8] Dietary intervention could play an important role in the control of obesity, dyslipidemia, and the regulation of endothelial function. [9] Implementation of treatment and prevention programs in childhood will be more eff ective than interventions in adulthood. [10] An increasing body of evidence suggests that increase in oxidative factors accounts for a significant proportion of endothelial dysfunction. In consequence, antioxidants administration are shown to be associated with improvement of coronary and peripheral endothelial function. [11] Epidemiological studies revealed an association between increased intakes of dietary antioxidants and reduced risk of coronary events. [12] Furthermore, it is documented that endothelial dysfunction could be reversed by the use of superoxide scavenging agents, including vitamin C and fl avonoids. [13] Many studies confi rmed the eff ects of fl avonoid-rich foods on reducing the markers of cardiovascular disease. [14] [15] [16] [17] Flavonoids, according to their structure, are reducing agents and can serve as effi cient chelators of transition metals involved in cellular oxidation reactions The association of fl avonoids, including Citrus fl avonoids, with metabolic disorders and atherosclerosis has been linked to their antioxidant properties and reducing oxidative stress. [18, 19] An inverse relationship is documented between fl avonoid consumption and heart disease risk factors as reducing blood pressure, improving fl ow-mediated dilatation (FMD), improving weight management, and dyslipidemia. [15] Limited experience exists on the role of dietary intervention with fruits rich in Vitamin C and fl avonoid on endothelial dysfunction in the pediatric age group. Citrus species fruits are considered to contain flavonoid, pectin, and vitamin C. [20] Lemon and sour orange are two Citrus species Persian fruits, which are popularly used among Iranians as natural additives to several foods and salads.
This study aims to investigate the effects of the peels of lemon (Citrus aurantifolia) and sour orange (Citrus aurantium) on endothelial function in adolescents with excess body weight.
MATERIALS AND METHODS
In this triple-masked, randomized controlled trial, 90 overweight adolescents were enrolled in a 1-month study period. The sample size was calculated by considering an α error of 0.05 and a β error of 20%, and also by considering the eff ect of fruit juices on FMD in a previous trial among obese children. [7] Participants and study design Trained physicians and nurses measured the height and weight of participants; body mass index (BMI) was calculated by dividing weight by the height squared (kg/m 2 ). For determining excess weight, we considered the revised growth charts of the Centers for Disease Control and Prevention, that is, the age-and gender-specifi c 85-95 th BMI percentile was considered as overweight, and >95 th percentile as obese. [21] To assess lifestyle habits including diet and physical activity, a validated questionnaire was used. It consisted of questions regarding demographic factors, consumption frequency of various foods, and the time spent on physical activity and sedentary habits. [6] In this study, we recruited subjects with 10-18 years of age, who had a BMI more than 85 th percentile. Those with endocrine disorders, and those who were active or passive smoker were not included to the trial.
For all participants who met the inclusion criteria, a cardiologist determined the FMD. Eligible participants were then randomly assigned into three groups of equal number receiving daily oral capsules containing lemon or sour orange powder or placebo.
Simple randomization was performed by using a random number table. The table was based on the numbers of participants' records. Participants, physicians, nurses, and the investigators were kept masked about the grouping.
The study medications were prepared in capsule form in Pharmacognosy Department of Isfahan University of Medical Sciences. Well-dried peels and external membranes of lemon (C. aurantifolia) and sour orange (C. aurantium) were used to prepare powder. They were bought from Isfahan and Sari markets (these cities are located in the center and North of Iran, respectively) and identifi ed in the Isfahan Pharmacognosy Department. For placebo receiving group cornstarch powder was prepared. [22] The powders were fi lled in capsules that were same in color and shape and size. Secret codes were defi ned for each group and then the medications were packed and delivered to the research center with similar labels to prevent study physician, nurses, and patients from knowing which medication was received.
The patients in first two groups received capsules containing 500 mg powdered peels of lemon or sour orange, twice a day for a period of 1 month. The third group received placebo (500 mg cornstarch) for a similar period of time. The FMD of all participants was assessed again a er the trial.
Flow-mediated dilatation
A single cardiologist conducted this study for all patients. He was also kept masked about the grouping of participants. Subjects were requested to fast for at least 8-12 h before the study. All vasoactive medications that might aff ect FMD such as caff eine, high-fat foods, and vitamin C were withheld for at least for at least 4-6 h before the assessment. Study medications for all three groups were also paused to use during this period of time. In addition, they were asked not exercise before the study. Participants were studied in a quiet, temperature controlled room. They were requested to lie on a fl at surface for 10 min to stabilize their blood pressure and heart rate. A erward, the baseline brachial artery diameter was determined by high-resolution B-mode sonography, using ALOKA 5000 system, 7.5 MHz transducer. The probe was placed 4-5 cm to the cubital fossa of the nondominating hand. Consequently, the pneumatic tourniquet of sphygmomanometer was infl ated around the upper part of the forearm to reach 300 Hg millimeter for 5 min. The cuff was then defl ated and the brachial diameter was again measured a er 90 s of cuff defl ation. The distance between tow external borders of the artery wall a er the diastolic phase is defi ned as artery diameter. The diff erence of artery diameter between before and a er infl ation is considered as FMD. [23] FMD percent change was defi ned as: FMD a er treatment -FMD baseline /FMD baseline .
Statistical analysis
Data were analyzed using paired t-test, independent t-test, and Chi-square tests, as well as repeated measures analysis of covariance a er adjustment for potential covariates as age, gender, dietary, and physical activity habits. P time , P group and P time × group were calculated for all variables. SPSS for Windows software (SPSS Inc., Chicago, IL, USA) version 20.0 was used for statistical analysis. The statistical signifi cance level was defi ned as P < 0.05.
RESULTS
The study flowchart is presented in Figure 1 . Of total 90 enrolled subjects, four were lost to follow-up: One refused to continue the trial, (1) due to moving of family to another city, and (2) did not return for follow-up. There was no statistically signifi cant diff erence in the number of withdrawals between the three groups (P = 0.09).
At the end of the trial, 30 participants (mean ± standard deviation [SD] of age = 13.7 ± 7.0 years; 13 boys and 17 girls) in the lemon group, 27 individuals (mean ± SD of age = 12.2 ± 9.2 years; 8 boys and 19 girls) in the Sour Orange group, and 29 subjects (mean ± SD of age = 13.2 ± 9.2 years; 10 boys and 19 girls) in the control group completed the study period. Comparison of age and gender showed no statistically signifi cant diff erence between three groups (P = 0.45 for age and P = 0.65 for gender). In addition, there was no significant difference between anthropometric measures in three groups. Details of comparisons are shown in Table 1 .
Before administration of medication, FMD was compared between three groups and no signifi cant diff erence was detected (P = 0.07). A er the trial, the anthropometric measures had no signifi cant change, but the mean FMD was signifi cantly (P < 0.001) higher in the lemon group (11.99 ± 4.05) and in the sour orange group (12.79 ± 5.47) than in those who were on placebo (6.45 ± 2.79). Treatment eff ects were noted by increase in mean FMD within the fi rst two groups, which were 5.50 ± 2.12 versus 5.55 ± 2.17 at baseline (P = 0.08), 11.99 ± 4.05 versus 12.79 ± 5.47 at the end of treatment period in the lemon and sour orange groups, respectively. FMD had no signifi cant change within the third group who received placebo which were 6.50 ± 2.43 at the baseline and 6.45 ± 2.79 at the end (P = 0.91).
FMD percent change was 145.02 ± 24.34 in the lemon group, 142.04 ± 16.11 in the sour orange group, and 46.73 ± 5.16 in controls (P < 0.001).
DISCUSSION
Our study showed that consumption of lemon and sour orange extracts, which contain plenty amounts of antioxidants, fl avonoids, pectin, and vitamin C might have signifi cant benefi ts on endothelial function in children and adolescents with excess weight.
Obesity is associated with molecular and cellular alterations in adipose tissue, as well as with various inflammatory processes. As the body fat increases, several pro-infl ammatory factors are produced in adipose tissue. Additionally, clinical and experimental data have demonstrated a link between systemic inflammation and endothelial dysfunction. Recent evidence show that disturbed endothelial function may be an early marker of an ongoing atherosclerotic process. [24] Serum markers of infl ammation and oxidative stress are linked to the early infl ammatory processes of atherosclerosis. [25] FMD of the brachial artery, used as a noninvasive endothelial function testing, shows early stages of endothelial dysfunction and is associated with the early infl ammatory state in obese children. [26] In this study, FMD was well improved in children who were treated with extracts of lemon and sour orange peels. These eff ects are suggested to be because of the antioxidative effects of their ingredients, including flavonoids, and vitamin C on endothelium function. Vitamin C inhibits peroxidation of membrane phospholipids and might have a scavenger role for free radicals; moreover it is necessary for the synthesis of several hormones and neurotransmi ers. Vitamin C may improve the function of immune system and may be useful for controlling inflammation; such eff ects include activities of antimicrobial and natural killer cells, lymphocyte proliferation, chemotaxis, and delayedtype hypersensitivity. [27] In previous studies, it has been documented that antioxidant therapy by supplementation of vitamins can improve the endothelial function in the pediatric age group. [28] Citrus fl avonoid, which is another main component in Citrus species, has marked potential activities in lowering serum lipid and lipoproteins, as well as in reducing the progression of atherosclerosis and endothelial dysfunction. [29] Flavonoids are suggested to act directly in decreasing the infl ammatory response within macrophages of the arterial intima, and therefore in slowing the progress of endothelial dysfunction and atherosclerosis. [30] Some eff ects might be mediated by increased hepatic glutathione peroxidase and superoxide dismutase activities, as well as decreased hepatic and plasma thiobarbituric acid reactive substances. [31] Moreover, experimental studies it might signifi cantly increase enzymes with antioxidant activity in pancreas and plasma, and might decrease serum activities of liver enzymes. [32] Consequently, consumption of fruits rich in vitamin C and fl avonoids could result in favorable changes in FMD, and might have protective eff ects against the process of atherosclerosis. Pectin as a soluble fi ber of Citrus fruits has also mild hypocholestrolemic eff ects. [33] The fi ndings of this study are also in line with the results of some other studies, which have investigated the use of antioxidant and other vitamin-rich fruits on endothelial function in adults. It is demonstrated that daily consumption of pomegranate juice for 3 months has benefi cial eff ects on improvement in FMD or endothelial function. Pomegranate is considered as an antioxidant-rich fruit; it is suggested that its certain natural antioxidants or fl avonoids are responsible for these eff ects on endothelial function. [34] Another study confi rmed that fl avonoids or some natural antioxidants might have strong effects on endothelial function; for instance, it is shown that daily ingestion of moderate amounts of grape juice might improve endothelial function in adult patients with atherosclerotic vascular diseases. [35] Similarly, in a study in the pediatric age group, daily consumption of natural grape and/or pomegranate juice had acute and long-term benefi ts on FMD of adolescents with metabolic syndrome. [36] It is suggested that parts of the benefi cial eff ects of Citrus peels might be because of their antioxidant activity. [37] Many recent review articles underscored the protective eff ects of Citrus fruits against atherosclerotic diseases and have suggested diff erent mechanisms. [38] [39] [40] [41] [42] The current fi ndings serve as confi rmatory evidence for such benefi cial eff ects from childhood.
Study limitations and strengths
One of the study limitations is the relatively small sample size, and this could be regarded as the main reason signifi cant between-group differences of assessed parameters are suggested to be studied in future investigations. Moreover, the treatment period in the current trial was limited to 1-month. This period may not have been suffi cient for detection of all signifi cant or nonsignifi cant diff erences between groups. Finally, it would be ideal to check proper cell mediators and other complementary serologic and biochemical factors in order to determine the treatment eff ects of lemon and sour orange, which was not possible in this study.
This study has strengths in a number of ways, that is, it was novel in the pediatric age group, moreover it was conducted as a triple masked and placebo-controlled trial, which causes elimination of selection and observational biases; moreover it was a randomized trial and the analyses were adjusted for potential confounders.
CONCLUSION
The findings of this trial suggest that consumption of extracts of lemon and sour orange peels might have signifi cant benefi ts on endothelial function in children and adolescents with excess weight. Longitudinal studies are necessary to assess the long-term clinical eff ects of these herbal extracts.
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